CyBio AG establishes new research subsidiary Innovative incubation technologies for medical active substance research

14-Feb-2001 - Germany

With CyBio Incusys GmbH, CyBio AG has established a subsidiary specialising in research and development of technologies for incubation, an important factor in medical active substance research. Components of fully-automatic laboratory environments in this sector include liquid handling (CyBio Instruments GmbH), incubation (CyBio Incusys GmbH), and detection and analysis (CyBio Systems GmbH). The subsidiary CyBio Software GmbH provides for coordination of the individual modules of the screening system and optimisation of test runs.

CyBio Instruments GmbH, developer of the CyBi™-Well simultaneous pipetter, leader in the world market, previously handled the responsibilities of CyBio Incusys. The establishment of the new subsidiary will now allow the current five employees to concentrate exclusively on the development of new technologies for incubation. At the same time the individual company can react more quickly to market demands. The managing directors of CyBio Incusys GmbH are Dr. Klaus Ettrich, from the management of CyBio Instruments GmbH, and Heinz Daugart, CEO of CyBio AG. By developing its own incubators, CyBio has taken the step toward becoming a supplier of complete systems and a system integrator of laboratory technologies in the entire preclinical phase of new medication development.

In the laboratories of pharmaceutical groups, fully-automatic laboratory environments speed up research on innovative medications. Incubation is an essential part of this: In test series, test substances from which an effect is expected are brought into contact with target molecules that trigger or influence diseases. In many cases a reaction can only be observed upon exposure to heat. This is provided by the incubator, which is similar to a brooding box. In mid-2000 CyBio presented an innovative short-cycle incubator, the CyBi™-Tower, which can warm up microplates with samples extremely quickly, thereby speeding up analysis. CyBio Incusys GmbH is currently working on new technologies that will allow temperatures to be regulated even more accurately.

https://www.chemeurope.com/en/news/1294/cybio-ag-establishes-new-research-subsidiary-innovative-incubation-technologies-for-medical-active-substance-research.html